Immunology research in older people, particularly humans, is advancing quickly as the importance of the immune system's ageing for the overall health of the organism becomes more apparent. The continued expansion of the elderly population in many nations throughout the world has stressed the importance of immunological ageing as a vital subject of research. Recent technology advancements have enabled researchers to investigate new areas of immunity and age-related alterations at the gene, cell, organismal, and societal levels. Immunosenescence is a phenomenon in which the immune response is actively modified as people age. This behaviour raises the risk of a variety of clinical diseases, including infections, autoimmune disorders, and cancer. Recent research has given light on the physiological components of immunosenescence, which is now seen to be an immunological adaptation to the ageing milieu rather than a system failure. Natural ageing is accompanied with biological changes in the immune system, some of which result in the immune system's deteriorating functions, as demonstrated by increasing vulnerability to respiratory diseases like influenza and new coronaviruses.
Title : Diagnosis and differentiation of lyme disease and tick-borne relapsing fever borreliosis with multiplex line immunoblots
Ranjan Ramasamy, IDFISH Technology, United States
Title : Mast cell degranulation links anti-PEG IgE to anaphylaxis caused by PEGylated drugs and PEG-contained LNP/mRNA COVID vaccines
Zhaohua Zhou, Food and Drug Administration, United States
Title : Genetic factors influencing early immunity to SARS-CoV-2 in the upper respiratory tract
Ranjan Ramasamy, IDFISH Technology, United States
Title : Monoclonal antibodies efficacy in treatment of novel coronavirus infection (COVID-19) in children at risk of developing a severe course of the disease
Ismail Osmanov, Children's city clinical hospital, Russian Federation
Title : Considerations on MS animal modeling: Format of myelin immunogens used for experimental autoimmune encephalomyelitis model establishment may affect pharmacologic responses of anti-inflammatory drugs
WenQing Yang, Founder/Chief Scientific Officer, ClinBridge Biotech Corp., China
Title : Regulatory T cells with chimeric antigen receptors as treatment for autoimmunity
Matthias Hardtke Wolenski, Hannover Medical School, Germany